| scholarly article | Q13442814 |
| P356 | DOI | 10.1128/JVI.76.19.9877-9887.2002 |
| P8608 | Fatcat ID | release_tg64diimsba3zfhlhsh2agp3iy |
| P3181 | OpenCitations bibliographic resource ID | 93981 |
| P932 | PMC publication ID | 136495 |
| P698 | PubMed publication ID | 12208965 |
| P2093 | author name string | Sheng-Yuan Wang | |
| Yun-Chi Chen | |||
| P2860 | cites work | Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES | Q24304260 |
| Dengue and dengue hemorrhagic fever | Q24550739 | ||
| Bacterial lipopolysaccharide inhibits dengue virus infection of primary human monocytes/macrophages by blockade of virus entry via a CD14-dependent mechanism. | Q27469350 | ||
| Release of vasoactive cytokines by antibody-enhanced dengue virus infection of a human mast cell/basophil line | Q27469685 | ||
| Infection of primary cultures of human Kupffer cells by Dengue virus: no viral progeny synthesis, but cytokine production is evident. | Q27469710 | ||
| Human dendritic cells are activated by dengue virus infection: enhancement by gamma interferon and implications for disease pathogenesis | Q27469896 | ||
| Cytokine regulation by virus infection: bovine viral diarrhea virus, a flavivirus, downregulates production of tumor necrosis factor alpha in macrophages in vitro | Q27480375 | ||
| Activation of endothelial cells via antibody-enhanced dengue virus infection of peripheral blood monocytes | Q27480826 | ||
| Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody | Q27485050 | ||
| Pathogenesis of dengue: challenges to molecular biology | Q27860978 | ||
| Human immunodeficiency virus gp120 inhibits interleukin-12 secretion by human monocytes: an indirect interleukin-10-mediated effect | Q28235309 | ||
| Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha | Q28251443 | ||
| Chemokines | Q29616435 | ||
| Human skin Langerhans cells are targets of dengue virus infection | Q29619564 | ||
| Clinical and laboratory observations on patients with primary and secondary dengue type 1 infections with hemorrhagic manifestations in Fiji | Q33497472 | ||
| Chemokines: extracellular messengers for all occasions? | Q33539653 | ||
| Immunopathogenesis of Dengue hemorrhagic fever | Q33597146 | ||
| Natural killer cells in antiviral defense: function and regulation by innate cytokines | Q33652468 | ||
| Expression of CCR5 increases during monocyte differentiation and directly mediates macrophage susceptibility to infection by human immunodeficiency virus type 1 | Q33784182 | ||
| Impact of dengue/dengue hemorrhagic fever on the developing world | Q33784757 | ||
| Cytokine cascade in dengue hemorrhagic fever: implications for pathogenesis | Q33949186 | ||
| Type I interferons and T helper development | Q34079320 | ||
| Activation of T lymphocytes in dengue virus infections. High levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and interferon-gamma in sera of children with dengue | Q34207386 | ||
| Increased susceptibility of differentiated mononuclear phagocytes to productive infection with human immunodeficiency virus-1 (HIV-1) | Q35596389 | ||
| Multinucleated giant cells generated in vitro. Terminally differentiated macrophages with down-regulated c-fms expression | Q35818196 | ||
| Caprine arthritis encephalitis virus dysregulates the expression of cytokines in macrophages. | Q35895488 | ||
| Type I interferons keep activated T cells alive | Q36367751 | ||
| Early murine cytomegalovirus (MCMV) infection induces liver natural killer (NK) cell inflammation and protection through macrophage inflammatory protein 1alpha (MIP-1alpha)-dependent pathways | Q36381040 | ||
| Epidemic dengue hemorrhagic fever in rural Indonesia. II. Clinical studies | Q36523464 | ||
| A chemokine-to-cytokine-to-chemokine cascade critical in antiviral defense | Q37176443 | ||
| Mononuclear phagocytes: tissue distribution and functional heterogeneity | Q39582204 | ||
| Viral-bacterial synergistic interaction in respiratory disease. | Q39609338 | ||
| Human cytomegalovirus productively infects primary differentiated macrophages | Q40115481 | ||
| Chemokines and tissue injury | Q40543142 | ||
| MIP-1 alpha and MIP-1 beta induction by dengue virus | Q40597001 | ||
| Failure of secondary infection with American genotype dengue 2 to cause dengue haemorrhagic fever | Q40630801 | ||
| Cytotoxic T lymphocytes in dengue virus infection | Q40631716 | ||
| Enhanced TNF alpha production by monocytic-like cells exposed to dengue virus antigens | Q40661419 | ||
| Effect of interferon-alpha and cell differentiation on Puumala virus infection in human monocyte/macrophages | Q40689683 | ||
| The differentiation state of monocytic cells affects their susceptibility to infection and the effects of infection by dengue virus | Q40696219 | ||
| High levels of interferon alpha in the sera of children with dengue virus infection | Q40721628 | ||
| Production of interferon alpha by dengue virus-infected human monocytes | Q40788729 | ||
| Hepatitis C virus core protein inhibits interleukin 12 and nitric oxide production from activated macrophages | Q40833771 | ||
| Human major group rhinoviruses downmodulate the accessory function of monocytes by inducing IL-10. | Q40851818 | ||
| Fatal hemorrhagic disease and shock associated with primary dengue infection on a Pacific island | Q40904992 | ||
| Dengue virus infection of human endothelial cells leads to chemokine production, complement activation, and apoptosis | Q40991574 | ||
| Impaired interleukin 12 production in human immunodeficiency virus-infected patients | Q41478389 | ||
| Regulation of Interferon Production by Human Monocytes: Requirements for Priming for Lipopolysaccharide-Induced Production | Q41673546 | ||
| Implication of macrophage inflammatory protein-1alpha in the inhibition of human haematopoietic progenitor growth by dengue virus | Q42989675 | ||
| A primary dengue 2 epidemic with spontaneous haemorrhagic manifestations | Q43049456 | ||
| Respiratory virus infection of peripheral blood monocytes: correlation with ageing of cells and interferon production in vitro | Q43420306 | ||
| Biological characterization of a granulomonopoietic enhancing activity derived from cultured human lipid-containing macrophages | Q43683423 | ||
| Interaction of strain AD169 and a clinical isolate of cytomegalovirus with peripheral monocytes: the effect of lipopolysaccharide stimulation | Q44440990 | ||
| A role for IFN-alpha beta in virus infection-induced sensitization to endotoxin | Q45738969 | ||
| Mechanism of suppression of cell-mediated immunity by measles virus | Q45770172 | ||
| Requirement of MIP-1 alpha for an inflammatory response to viral infection. | Q52509286 | ||
| Synergistic inhibition of human marrow granulocyte-macrophage progenitor cells by prostaglandin E and recombinant interferon-alpha, -beta, and -gamma and an effect mediated by tumor necrosis factor | Q58414574 | ||
| Heterogeneity of human blood monocyte: two subpopulations with different sizes, phenotypes and functions | Q67924876 | ||
| Long-term culture of human bone marrow macrophages: macrophage development is associated with the production of granulomonopoietic enhancing activity (GM-EA) | Q69896733 | ||
| Down regulation of myelopoiesis by mediators inhibiting the production of macrophage-derived granulomonopoietic enhancing activity (GM-EA) | Q70412783 | ||
| The macrophage | Q70800371 | ||
| Differentiation of phagocytic monocytes into lymph node dendritic cells in vivo | Q73336913 | ||
| Inhibition of IL-12 production in human monocyte-derived macrophages by TNF | Q73406955 | ||
| Dermal-resident CD14+ cells differentiate into Langerhans cells | Q77149823 | ||
| Interleukin-12: a cytokine at the interface of inflammation and immunity | Q77355814 | ||
| Synergism for cytokine-mediated disease during concurrent endotoxin and viral challenges: roles for NK and T cell IFN-gamma production | Q77399312 | ||
| Role of early cytokines, including alpha and beta interferons (IFN-alpha/beta), in innate and adaptive immune responses to viral infections | Q77502609 | ||
| P433 | issue | 19 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | macrophage | Q184204 |
| lipopolysaccharide | Q421804 | ||
| Dengue virus | Q476209 | ||
| P304 | page(s) | 9877-9887 | |
| P577 | publication date | 2002-10-01 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Activation of terminally differentiated human monocytes/macrophages by dengue virus: productive infection, hierarchical production of innate cytokines and chemokines, and the synergistic effect of lipopolysaccharide | |
| P478 | volume | 76 |
| Q64060301 | A balanced game: chicken macrophage response to ALV-J infection |
| Q35235639 | A detrimental role for invariant natural killer T cells in the pathogenesis of experimental dengue virus infection |
| Q34644801 | A paradoxical role for neutrophils in the pathogenesis of West Nile virus |
| Q34359759 | Adenovirus delivered short hairpin RNA targeting a conserved site in the 5' non-translated region inhibits all four serotypes of dengue viruses |
| Q27473379 | American Genotype Structures Decrease Dengue Virus Output from Human Monocytes and Dendritic Cells |
| Q34552933 | An external loop region of domain III of dengue virus type 2 envelope protein is involved in serotype-specific binding to mosquito but not mammalian cells |
| Q56340954 | An hPSC-Derived Tissue-Resident Macrophage Model Reveals Differential Responses of Macrophages to ZIKV and DENV Infection |
| Q40429067 | An in vitro model for dengue virus infection that exhibits human monocyte infection, multiple cytokine production and dexamethasone immunomodulation |
| Q43039465 | Antagonistic expression of hepatitis C virus and alpha interferon in lymphoid cells during persistent occult infection. |
| Q25708015 | Antibody-Dependent Enhancement of Dengue Virus Infection in Primary Human Macrophages; Balancing Higher Fusion against Antiviral Responses |
| Q40064311 | Antiviral and Immunomodulatory Effects of Norantea brasiliensis Choisy on Dengue Virus-2. |
| Q40457185 | Attenuating characteristics of DEN-2 PDK53 in flavivirus-naïve peripheral blood mononuclear cells. |
| Q38905651 | Bacterial coinfections in dengue virus disease: what we know and what is still obscure about an emerging concern. |
| Q24315236 | CLEC5A is critical for dengue-virus-induced lethal disease |
| Q35864402 | Comparative evaluation of permissiveness to dengue virus serotype 2 infection in primary rodent macrophages |
| Q40386249 | Cytokine and nitric oxide production by mouse macrophages infected with Brazilian flaviviruses |
| Q27469822 | Dendritic cell precursors are permissive to dengue virus and human immunodeficiency virus infection |
| Q27481475 | Dengue Virus (DV) Replication in Monocyte-Derived Macrophages Is Not Affected by Tumor Necrosis Factor Alpha (TNF- ), and DV Infection Induces Altered Responsiveness to TNF- Stimulation |
| Q91868242 | Dengue Virus Infection Activates Interleukin-1β to Induce Tissue Injury and Vascular Leakage |
| Q27490477 | Dengue Virus Infection Induces Upregulation of GRP78, Which Acts To Chaperone Viral Antigen Production |
| Q36280060 | Dengue Virus-Induced Inflammation of the Endothelium and the Potential Roles of Sphingosine Kinase-1 and MicroRNAs. |
| Q35865823 | Dengue and soluble mediators of the innate immune system |
| Q40140011 | Dengue virus NS1 protein activates cells via Toll-like receptor 4 and disrupts endothelial cell monolayer integrity |
| Q40289267 | Dengue virus entry as target for antiviral therapy |
| Q54216769 | Dengue virus induces increased activity of the complement alternative pathway in infected cells. |
| Q38158411 | Dengue virus infection: current concepts in immune mechanisms and lessons from murine models |
| Q27470758 | Dengue virus nonstructural protein NS5 induces interleukin-8 transcription and secretion |
| Q24645380 | Dengue virus pathogenesis: an integrated view |
| Q26700116 | Dengue virus requires the CC-chemokine receptor CCR5 for replication and infection development |
| Q42989483 | Dengue virus: molecular basis of cell entry and pathogenesis, 25-27 June 2003, Vienna, Austria |
| Q40366732 | Dengue-2 infection and the induction of apoptosis in human primary monocytes |
| Q40177309 | Dermal CD14(+) Dendritic Cell and Macrophage Infection by Dengue Virus Is Stimulated by Interleukin-4. |
| Q40488614 | Detection of serum neopterin for early assessment of dengue virus infection |
| Q27485005 | Differential Activation of Human Monocyte-Derived and Plasmacytoid Dendritic Cells by West Nile Virus Generated in Different Host Cells |
| Q27002464 | Distinct regulation of dengue virus-induced inflammasome activation in human macrophage subsets |
| Q58570199 | Dynamic modulation of DC-SIGN and FcΥR2A receptors expression on platelets in dengue |
| Q36086727 | Endothelial cells elicit immune-enhancing responses to dengue virus infection |
| Q38272173 | Endothelial dysfunction in dengue virus pathology |
| Q90798978 | Flavivirus infection-A review of immunopathogenesis, immunological response, and immunodiagnosis |
| Q40519496 | Gene expression in human macrophages infected with dengue virus serotype-2. |
| Q33945948 | Gene expression profiling of dengue infected human primary cells identifies secreted mediators in vivo |
| Q39034933 | IL-22 modulates IL-17A production and controls inflammation and tissue damage in experimental dengue infection |
| Q55452170 | Identification of genetic variants associated with dengue or West Nile virus disease: a systematic review and meta-analysis. |
| Q35613349 | Immunology and immunopathogenesis of dengue disease |
| Q40315102 | Immunosuppressive effects and mechanisms of leflunomide in dengue virus infection of human dendritic cells |
| Q96172041 | Implications of antibody-dependent enhancement of infection for SARS-CoV-2 countermeasures |
| Q33623765 | Increased TLR4 expression and downstream cytokine production in immunosuppressed adults compared to non-immunosuppressed adults |
| Q24813351 | Inducible nitric oxide synthase (iNOS) expression in monocytes during acute Dengue Fever in patients and during in vitro infection |
| Q59354754 | Interleukin-33 contributes to disease severity in Dengue virus infection in mice |
| Q42483961 | Lipopolysaccharide-induced miR-1224 negatively regulates tumour necrosis factor-α gene expression by modulating Sp1. |
| Q24570135 | Maturation of dengue virus nonstructural protein 4B in monocytes enhances production of dengue hemorrhagic fever-associated chemokines and cytokines |
| Q34746720 | Microbial translocation is associated with extensive immune activation in dengue virus infected patients with severe disease |
| Q35009344 | Minimal within-host dengue models highlight the specific roles of the immune response in primary and secondary dengue infections |
| Q38045381 | Molecular mechanisms involved in antibody-dependent enhancement of dengue virus infection in humans |
| Q27486434 | Multiplex cytokine profile from dengue patients: MIP-1beta and IFN-gamma as predictive factors for severity |
| Q39843134 | N-linked glycans on dengue viruses grown in mammalian and insect cells |
| Q37400186 | Nitric oxide in dengue and dengue haemorrhagic fever: necessity or nuisance? |
| Q28081774 | Overcoming tumor immune evasion with an unique arbovirus |
| Q37187338 | Potential evidence for biotype-specific chemokine profile following BVDV infection of bovine macrophages |
| Q27485010 | Primary Human Splenic Macrophages, but Not T or B Cells, Are the Principal Target Cells for Dengue Virus Infection In Vitro |
| Q40614690 | Productive replication of nephropathogenic infectious bronchitis virus in peripheral blood monocytic cells, a strategy for viral dissemination and kidney infection in chickens |
| Q42996855 | Replication of West Nile virus in equine peripheral blood mononuclear cells |
| Q46605151 | Rotavirus degrades multiple type interferon receptors to inhibit IFN signaling and protects against mortality from endotoxin in suckling mice |
| Q52568182 | SIRT6 Acts as a Negative Regulator in Dengue Virus-Induced Inflammatory Response by Targeting the DNA Binding Domain of NF-κB p65. |
| Q90040666 | Serum LPS Associated with Hantavirus and Dengue Disease Severity in Barbados |
| Q38023832 | Staphylococcus aureus pneumonia and dengue virus co-infection and review of implications of coinfection |
| Q40051336 | Suppression of chikungunya virus replication and differential innate responses of human peripheral blood mononuclear cells during co-infection with dengue virus |
| Q34264672 | Susceptibility and response of human blood monocyte subsets to primary dengue virus infection |
| Q33548699 | T cell-dependence of Lassa fever pathogenesis |
| Q63246534 | T-Cell Response to Viral Hemorrhagic Fevers |
| Q27490919 | Targeted Delivery of Small Interfering RNA to Human Dendritic Cells To Suppress Dengue Virus Infection and Associated Proinflammatory Cytokine Production |
| Q90582166 | The Difference of sVE-Cadherin Levels between Dengue Hemorrhagic Fever Patients with Shock and without Shock |
| Q34254517 | The implication of aberrant GM-CSF expression in decidual cells in the pathogenesis of preeclampsia |
| Q58582556 | The monocyte-macrophage-mast cell axis in dengue pathogenesis |
| Q56797768 | Valproic Acid Downregulates Cytokine Expression in Human Macrophages Infected with Dengue Virus |
| Q40167695 | Vascular leakage in dengue hemorrhagic Fever is associated with dengue infected monocytes, monocyte activation/exhaustion, and cytokines production |
| Q27486878 | Viral replication and paracrine effects result in distinct, functional responses of dendritic cells following infection with dengue 2 virus |
| Q27488297 | West Nile Virus Attenuates Activation of Primary Human Macrophages |
Search more.